On September 25, 2015, the Centers for Medicare and Medicaid Services (CMS) issued a pre-publication copy of the Clinical Laboratory Fee Schedule (CLFS) proposed rule. The proposed rule restructures payment rates for clinical diagnostic laboratory tests (CDLTs) and advanced diagnostic
A relator is dropping his appeal of a district court decision that granted a motion to dismiss FCA claims against CVS. Procedural deficiencies were raised with relator’s appeal, including missing the filing deadline for his appeal in the U.S. Court
The government has announced that a South Florida hospital district will pay $69.5 million to settle False Claims Act allegations related to financial arrangements with physicians.
This case follows the trend of increased scrutiny of physician compensation, both by whistleblowers
On Wednesday September 9, 2015, the U.S. Department of Justice (“DOJ” or the “Department”) issued a memorandum entitled “Individual Accountability For Corporate Wrongdoing” (the “Memo”) outlining specific policy measures intended to empower U.S. prosecutors further in their pursuit of
Following extensive outreach with the stakeholder community and publication of four notices of proposed rulemaking, on September 10, 2015, the Food and Drug Administration (FDA) and the Department of Health and Human Services (HHS) issued the much anticipated Final Rules
On Wednesday, a federal district court in Washington, DC ruled that the House of Representatives had standing to bring claims against the Obama administration regarding healthcare spending under the Affordable Care Act. That is, the court found that the House
On September 2, the US Department of Health and Human Services (HHS), along with 15 other government agencies, proposed changes to the Common Rule, to enhance protections for individuals involved in research, while modernizing rules and improving efficiency. The rule
Today, the Department of Health and Human Services (“HHS”) issued a long-awaited proposed rule implementing Section 1557 of the Affordable Care Act (“ACA”), which makes clear that the ACA’s extension of civil rights protections against sex discrimination in health programs
Kim Kardashian is promoting Diclegis® on social media once again. But this time, she is posting about the drug to correct her prior actions.
On August 12, we discussed Kim Kardashian’s Instagram and Facebook post in which she discussed the
A California woman has filed a class action lawsuit in federal court against Chipotle Mexican Grill, Inc. (“Chipotle”) taking issue with Chipotle’s ads touting its restaurants as serving only ingredients that are free from genetically modified organisms (“GMOs”).
Colleen Gallagher